Revenue Breakdown
Composition ()
No data
Revenue Streams
Lumexa Imaging Holdings Inc (LMRI) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is OUTPATIENT, accounting for 74.4% of total sales, equivalent to $187.90M. Other significant revenue streams include PROFESSIONAL and INTERSEGMENT ELIMINATIONS. Understanding this composition is critical for investors evaluating how LMRI navigates market cycles within the Healthcare Facilities & Services industry.
Profitability & Margins
Evaluating the bottom line, Lumexa Imaging Holdings Inc maintains a gross margin of 9.84%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at 3.52%, while the net margin is 0.68%. These profitability ratios, combined with a Return on Equity (ROE) of N/A, provide a clear picture of how effectively LMRI converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, LMRI competes directly with industry leaders such as TALK and DNA. With a market capitalization of $746.55M, it holds a significant position in the sector. When comparing efficiency, LMRI's gross margin of 9.84% stands against TALK's 39.04% and DNA's 84.09%. Such benchmarking helps identify whether Lumexa Imaging Holdings Inc is trading at a premium or discount relative to its financial performance.
